Turning Point Brands Canada Becomes Exclusive Distributor for VPRB's HoneyStick in Canada

Business by 2FIRSTS.ai
Jan.09.2024
Turning Point Brands Canada Becomes Exclusive Distributor for VPRB's HoneyStick in Canada
VPR Brands announces Turning Point Brands Canada as the exclusive distributor of its HoneyStick products in Canada.

VPR Brands (OTC: VPRB) recently announced that Turning Point Brands Canada (TPB) will serve as the exclusive distributor for its HoneyStick products in Canada.

 

VPR Brands (VPRB) is an e-cigarette manufacturer dedicated to introducing innovative products.

 

TPB is a Canadian marketing and distribution company in the field of tobacco, e-cigarettes, and alternative products.

 

HoneyStick is set to join TPB Canada's portfolio of leading global brand management, alongside iconic brands such as Zig-Zag, Clipper, Choice Leaf, HMP, Rebound, and Evolve, to enter the Canadian market.

 

In the future, TPB Canada will streamline the retail process by centralizing ordering, logistics, and warehousing in one location. This will ensure a steady supply of HoneyStick products and reduce delivery times, enabling faster product delivery across Canada.

 

Currently, HoneyStick has launched on the Canadian e-commerce platform tpbmarketplace. However, it is either marked as "sold out" or yet to be available on several other Canadian e-commerce platforms.

 

Mikail Fancy, Chief Operating Officer of Turning Point Brands Canada, expressed enthusiasm over the partnership with VPR Brands to bring HoneyStick to a wider audience in Canada. Fancy highlighted the combination of their expertise in marketing, sales, distribution, and logistics, along with the quality and innovation of HoneyStick products, as a perfect match. He emphasized their commitment to providing excellent service and support for retailers and consumers.

 

Daniel Hoff, Chief Operating Officer of VPR Brands, has stated that the collaboration with Turning Point Brands Canada is a significant milestone for HoneyStick in Canada. Their strong distribution network and successful experience in marketing, sales, and customer service make them an ideal partner to enhance our brand's presence and accessibility nationwide.

 

VPR is currently involved in a significant case regarding a legal dispute with IMiracle (Heaven Gifts). The main point of contention revolves around the usage rights of the term "Elf" on e-cigarette products.

 

VPR filed a lawsuit in October 2022 against the distributor Shenzhen Weibo Li Technology Co., Ltd and the manufacturer iMiracle (HK) Limited, alleging infringement of VPR's trademark rights on ELF during the sales of Elfbar. Elfbar is the most popular disposable e-cigarette brand among young users.

 

In response, Judge Cannon in the United States issued a temporary injunction on Chinese companies in February 2023, prohibiting them from selling any e-cigarette products bearing the name ELFBAR. Judge Cannon stated that there is currently "no dispute" that these companies intentionally infringed upon VPR's trademark rights.

 

Shenzhen V-Perfect and iMiracle have submitted their first document claiming that they can prove V-Perfect is not the original user of the ELF trademark. According to the documents submitted by these two companies on April 24th, they have discovered the true owner of the ELF trademark, another Chinese company called GD Sigelei Electronic Tech. This company first used the "ELF" to sell e-cigarette products in April 2016, almost a year and a half earlier than V-Perfect's first batch of ELF products.

 

In March of this year, two Chinese companies signed a trademark transfer agreement, claiming to have transferred the rights to the Elf trademark to iMiracle. Based on this, they have requested Judge Cannon to revoke the temporary injunction.

 

Another important document claims that VPR has utilized a court order prohibiting them from manufacturing ELFBAR in order to seek market share. According to the document from May, VPR has launched a "blatantly imitated" ELFBAR disposable e-cigarette, clearly copying iMiracle's product. Both of these Chinese companies argue that these inferior counterfeit products will confuse consumers, ultimately leading to ELFBAR losing market share and reputation.

 

Although both parties have informed the mediators that Judge Cannon's decision on these two motions will "guide their positions for settlement," the case remains at a standstill, waiting for the Chinese companies to appeal to the Federal Circuit in an attempt to overturn the injunction. These two Chinese companies are dissatisfied with the temporary ban and stated in their submission to the Federal Circuit that the injunction is erroneous and has resulted in them losing millions of dollars.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
Former BAT global content lead Andy Parton has left the company and launched Destreza, a London-based AI-native marketing consultancy. Parton previously worked across BAT's New Category brands Vuse, Velo and glo and had also served as Global Brand Lead for Vuse Go. Destreza says it will advise consumer businesses on AI in brand strategy, operating models, capability and agency configuration, using specialist AI agents to support research, strategy and creative development. BAT reported £3.621 billion in New Category revenue in 2025.
Sep.22
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
China’s Shanghai Tobacco Group Launches CNY 10.98 Million (Approximately US$1.53 Million) Procurement for Heated Tobacco Production Utility Equipment
China’s Shanghai Tobacco Group Launches CNY 10.98 Million (Approximately US$1.53 Million) Procurement for Heated Tobacco Production Utility Equipment
Shanghai Tobacco Group Co., Ltd., a tobacco manufacturing company under China National Tobacco Corporation (CNTC), has launched a public tender for heated tobacco products (HTPs) production utility equipment at its Shanghai Cigarette Factory. The project is valued at CNY 10.98 million and covers six combined air-conditioning units, electrical cabinets and control systems for production facilities. The procurement includes equipment design, supply, installation, commissioning and related training services.
Aug.07
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18